ABVC: Multiplikator P/S ABVC BioPharma Inc.
P/S volatility on GURU.Markets reflects the market risks facing ABVC BioPharma in the presence of major pharma behemoths, with the current parameter equal to 43.70. ABVC BioPharma develops plant-based treatments for ADHD and depression, scaling sales through global licensing. The asset's value growth is based on FDA approvals, patent expansion, and payments from Asian partners.
ABVC BioPharma Inc (ABVC) - rincian metrik lan laporan keuangan
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- data ekuitas miturut neraca:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas ABVC BioPharma|ABVC - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ABVC BioPharma, Inc|ABVC - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku ABVC BioPharma Inc|ABVC - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak ABVC BioPharma|Likuiditas darurat abvcpharma.com
- rincian asil keuangan lan kelipatan valuasi:
ABVC - Bathi resik perusahaan|Bathi forward ABVC BioPharma|ABVC - Pangali P/E|Pangali mangsa ngarep rega marang bathi ABVC BioPharma Inc.|ABVC - Pangali PEG|Pangali EV/EBITDA ABVC BioPharma Inc|ABVC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku ABVC BioPharma|ABVC - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan abvcpharma.com|ABVC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep ABVC BioPharma
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis umum perusahaan:abvcpharma.com ABVC
Professional managers utilize fundamental filters to separate overvalued assets from those with growth potential. The P/S ratio compares market capitalization to annual revenue, determining the cost of one ruble of sales within the share price. For ABVC BioPharma, which depends on investments and research outcomes, this metric reflects market expectations for future products. Analyzing the P/S ratio chart helps balance risk and potential return.
Perusahaan pesaing
HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S KVUE (Kenvue)|Multiplikator P/S Verona Pharma PLC VRNA|Jyong Biotech Corp - Multiplikator P/S|LGND: Rasio rega marang pendapatan|AMRX (Amneal Pharmaceuticals) - Kapitalisasi marang pendapatan|PRGO (perrigo.com) - Rasio rega marang pendapatan|ALVO (Alvotech SA) - Multiplikator P/S|Kapitalisasi marang pendapatan Liquidia Corp (LQDA)|Kapitalisasi marang pendapatan GLPG (Galapagos Genomics)|ANIP (ANI Pharmaceuticals Corp) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MNKD (MannKind Corporation)|amphastar.com - Rasio rega marang pendapatan|Pacira BioSciences, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan ARS Pharmaceuticals Inc SPRY|Theravance (TBPH) - Rasio rega marang pendapatan|Rega marang dodolan Aquestive Corp (AQST)|Rasio rega marang pendapatan scPharmaceuticals, Inc.|Tectonic - Rasio rega marang dodolan|Multiplikator P/S TNXP|SXTC (sxtchina.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S EPRX (Eupraxia Pharmaceuticals Inc.)|Multiplikator P/S BioHarvest Sciences Inc BHST|EXOZ - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ORMP (Oramed Pharmaceuticals)|enterabio.com (ENTX) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan MindWalk Holdings, Inc.|CPIX (Cumberland Pharma) - Multiplikator P/S|Multiplikator P/S Quantum BioPharma Corp|Multiplikator P/S FGEN|Multiplikator P/S telomirpharma.com (TELO)|Multiplikator P/S RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. - Rasio rega marang pendapatan|RLYB: Kapitalisasi marang pendapatan|LEXX: Rasio rega marang pendapatan|PULM: Multiplikator P/S|Kapitalisasi marang pendapatan Pheton Holdings|Rasio rega marang pendapatan Aptorum Group Ltd|Lyra Therapeutics Inc. - Rasio rega marang dodolan|Multiplikator P/S IBO|TNFA (tnfpharma.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S YCBD (cbdMD)|Multiplikator P/S painreform.com PRFX|CYTO - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan LIPO (Lipella Pharmaceuticals Inc)|Optinose (OPTN) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Pieris Pharma|PROC (Procaps Group S.A.) - Multiplikator P/S|Multiplikator P/S petrospharma.com|Kapitalisasi marang pendapatan QLI (Qilian International Holding)|SLRN (Acelyrin Inc.) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan TFF Pharma TFFP
